22nd Century Group (XXII) stock: a solid upside?

9:09 am ET, 08 Aug 2018

22nd Century Group, Inc (XXII) reported its Q2 yesterday.  The EPS was -$0.05, while revenue grew 77% to $6.92M.  

Is XXII a good investment? What's XXII stock price forecast, and what should investors know about the stock?

22nd Century Group is a little biotech developing technology which allows the increase or decrease in the level of nicotine and other nicotinic alkaloids in tobacco plants.  The company also has the technology to control levels of cannabinoids in cannabis plants.  

The shares have appreciated lately, which is a normal occurrence for a news-driven stock.  XXII has an attractive risk-reward profile: its modified risk tobacco product (MRTP) status is the obvious catalyst, as the FDA tightens up the regulation of nicotine levels in cigarettes.

XXII's timing for MRTP is right since the FDA plans to mandate nicotine levels.  The drug will open up a lot of commercial opportunities.

We looked at the sentiment analysis for the XXII stock. Our technical analysis shows that:

  • The stock short-term sentiment (next 30 days) is negative;
  • The mid-term sentiment (3-6 months) is trending positive;
  • The long-term sentiment (9-12 months) is negative. 


Over the last month, 22nd Century Group, Inc (XXII) returned -7.04%.

22nd Century Group, Inc (XXII) average analyst price target ($11.50) is 358.17% above its current price ($2.51).

For the latest price and information on 22nd Century Group, Inc, please visit Finstead and search for "XXII price" or "XXII news".

22nd Century Group, Inc (XXII) Stock Guide

Updated at: 9:05 pm ET, 18 Sep 2020

Before we start: if you're looking for XXII stock price, you can quickly find it out by visiting Finny and typing "XXII quote". If you're looking for a quick scoop on XXII stock (chart, price target, market cap, news and buy or sell analysis), go to Finny and look for "XXII". You'll get all this info in one place. Or you can just type "XXII news" to get the latest stock news.

Looking to buy or sell 22nd Century Group, Inc (XXII)? Interested in getting the full scoop on XXII, including earnings and dividends, stock forecast, buy or sell analysis and key stats? If so, you came to the right place.

In this XXII stock guide, we'll address key questions about XXII, above and beyond what you can find on Yahoo Finance, Zacks, MarketWatch or Morningstar.

Here is what you'll be able to find in this guide:

Earnings and Dividends: earnings, earnings date, dividend rate and dividend yield;
Analyst Predictions: stock forecast and analyst ratings;
Analysis: Finny Score and buy or sell analysis;
Key Stats: revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio, industry, sector, and number of employees.

And here is the list of questions we'll answer:
1. What are XXII earnings?
2. What is XXII stock forecast (i.e., prediction)?
3. XXII buy or sell? What is XXII Finny Score?
4. What are the reasons to buy XXII? Why should I buy XXII stock?
5. What are the reasons to sell XXII? Why should I sell XXII stock?
6. What are XXII key stats: revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio industry, sector, and number of employees?

So let's start. Scroll down to the question that interests you the most.

Earnings and Dividends

1. What are XXII earnings?

XXII trailing 12-month earnings per share (EPS) is -$0.19.

Analyst Predictions

2. What is XXII stock forecast (i.e., prediction)?

Based on XXII analyst price targets, XXII stock forecast is $4.00 (for a year from now). That means the average analyst price target for XXII stock is $4.00. The prediction is based on 1 analyst estimates.

The low price target for XXII is $4.00, while the high price target is $4.00.

XXII analyst rating is Buy.

Analysis

3. XXII buy or sell? What is XXII Finny Score?

#{finnyScore:80}Our quantitative analysis shows 8 reasons to buy and 2 reasons to sell XXII, resulting in Finny Score of 80.

4. What are the reasons to buy XXII? Why should I buy XXII stock?

Here are the reasons to buy XXII stock:

5. What are the reasons to sell XXII? Why should I sell XXII stock?

Let's look at the reasons to sell XXII stock (i.e., the bear case):

  • XXII short share of float is 7.76%. The stock is much more frequently shorted than the average industry, sector or S&P 500 stock. See XXII short share of float chart.
  • XXII short interest (days to cover the shorts) ratio is 8.9. The stock garners more short interest than the average industry, sector or S&P 500 stock. See XXII short interest ratio chart.

Key Stats

6. What are XXII key stats : revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio industry, sector, and number of employees?

Let's look at the key statistics for XXII:

Metrics XXII
Price $0.64
Average Price Target / Upside $4.00 / 523.93%
Average Analyst Rating Buy
Forward Dividend Yield 0.00%
Industry Biotechnology
Sector Healthcare
Number of Employees 82
Market Cap $85.85M
Forward P/E Ratio -3.86
Price/Book Ratio 3.15
Revenue (TTM) $27.22M
YoY Quarterly Revenue Growth 10.70%
Profit Margin -93.80%

If you liked this analysis, check out Stock Guides for other stocks.

Follow Us